Pyelonephritis following phenazopyridine use

Published:November 30, 2016DOI:


      We present a case of pyelonephritis following the extended andsolitary use of over-the-counter phenazopyridine in a forty-year-oldfemale. The patient initially had uncomplicated cystitis signs andsymptoms which partially resolved with phenazopyridine and therefore she continued use. She presented to the emergency department with systemicsigns and symptoms of acute pyelonephritis. As phenazopyridine is devoidof antibacterial properties this allowed the lower urinary tractinfection to progress to acute pyelonephritis requiring intravenousantibiotics. Better patient education may preclude this complication.
      To read this article in full you will need to make a payment
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of Emergency Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Foxman B.
        Epidemiology of urinary tract infections: incidence, morbidity, and economic costs.
        Am J Med. 2002; 113: 5S-13S
        • Shaikh N.
        • Mattoo T.J.
        • Keren R.
        • et al.
        Early antibiotic treatment for pediatric febrile urinary tract infection and renal scarring.
        JAMA Pediatr. 2016; 170: 848-854
        • Gaines K.K.
        Phenazopyridine hydrochloride: the use and abuse of an old standby for UTI.
        Urol Nurs. 2004; 24: 207-209
        • Jeffery W.H.
        • Zelicofff A.P.
        • Hardy W.R.
        Acquired methemoglobinemia and hemolytic anemia after usual doses of phenazopyridine.
        Drug Intell Clin Pharm. 1982; 16: 157-159
        • Goldfinger S.E.
        • Marx S.
        Hypersensitivity hepatitis due to phenazopyridine hydrochloride.
        N Engl J Med. 1972; 286: 1090-1091
        • Cazzulani P.
        • Panzarasa R.
        • Luca C.
        • et al.
        Pharmacological studies on the mode of action of flavoxate.
        Arch Int Pharmacodyn Ther. 1984; 268: 301-302
        • Gould S.
        Clinical comparison of flavoxate and phenazopyridine.
        Urology. 1975; 5: 612-615
        • Semigan H.L.
        • Linder J.A.
        • Gidengil C.
        • et al.
        Evaluation of symptom checkers for self-diagnosis and triage: audit study.
        BMJ. 2015; 531: h3480
      1. Best over the counter bladder infection treatment.
        ([Accessed November 28, 2016])